Allogene Therapeutics ALLO Business Segments — Payroll

Similar metrics at other companies

BNEDReportable Segment — Payroll expense

$51.37M+0.5%

WEAVReportable Segment — Payroll and employee-related costs

$42.68M+2.5%

MSMReportable Segment — Payroll and payroll-related costs

$171.2M-1.2%

BFLYReportable segment — Payroll operating expenses

$15.3M+5.5%

VVVReportable Segment — Payroll and related costs

$38.5M+26.2%

SVCOReportable Segment — Payroll expenses

$16.35M+12.5%

Questions, answered.

What is Allogene Therapeutics's business segments — payroll?

Allogene Therapeutics (ALLO) reported business segments — payroll of $14.44M in Q1 2026.

How has Allogene Therapeutics's business segments — payroll changed year-over-year?

Allogene Therapeutics's business segments — payroll decreased by 26.3% year-over-year, from $19.6M to $14.44M.

What is the long-term trend for Allogene Therapeutics's business segments — payroll?

Over 2 years (2023 to 2025), Allogene Therapeutics's business segments — payroll has grown at a -15.4% compound annual growth rate (CAGR), from $87.85M to $62.91M.

What does business segments — payroll mean?

This metric measures the total compensation and benefits costs for personnel directly associated with the reportable segment's operations. It serves as a proxy for the human capital investment required to sustain clinical development and operational activities. Changes in this figure often indicate shifts in headcount or organizational scaling.